Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that there have been significant improvements in diagnosing and treating skin diseases, including melanoma, with new techniques and therapies.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Nonmelanoma skin cancers have higher levels of certain osteopontin variants than normal skin.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Targeted cancer therapies often cause serious skin problems that need careful management.

High lactate dehydrogenase activity is not necessary for the growth of squamous cell carcinoma.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Blocking both main energy pathways can stop hair follicle stem cell-induced skin cancer growth.

A 70-year-old man with skin cancer on both sides of his forehead was treated with surgery and cryotherapy, highlighting the need for early detection and prevention.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Most people with basal cell carcinoma on their head or neck were 60-70 years old, and it often came back even after being fully removed, especially in certain areas and types.

Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.

Basal cell carcinomas may differentiate similarly to hair follicles and could be influenced by hair cycle-related treatments.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

Some aggressive scalp cancers are hard to treat and can be deadly, even when removed with specialized surgery.

Scalp basal cell carcinoma may be more aggressive and harder to treat than other types, requiring special attention and further research.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.